Diana Kostyalik
Overview
Explore the profile of Diana Kostyalik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kostyalik D, Kelemen K, Lendvai B, Hernadi I, Roman V, Levay G
Sci Rep
. 2022 May;
12(1):8168.
PMID: 35581280
The human mu rhythm has been suggested to represent an important function in information processing. Rodent homologue rhythms have been assumed though no study has investigated them from the cognitive...
2.
Nemethy Z, Kiss B, Lethbridge N, Chazot P, Hajnik T, Toth A, et al.
Eur J Pharmacol
. 2021 Dec;
916:174621.
PMID: 34965389
The histamine H receptor is a favourable target for the treatment of cognitive deficits. Here we report the in vitro and in vivo profile of RGH-235, a new potent, selective,...
3.
Ledneczki I, Horvath A, Tapolcsanyi P, Eles J, Molnar K, Vago I, et al.
Eur J Med Chem
. 2021 Jun;
222:113560.
PMID: 34111828
HTS campaign of the corporate compound collection resulted in a novel, oxalic acid diamide scaffold of α7 nACh receptor positive allosteric modulators. During the hit expansion, several derivatives, such as...
4.
Papp N, Koncz S, Kostyalik D, Kitka T, Petschner P, Vas S, et al.
Front Pharmacol
. 2020 Feb;
10:1636.
PMID: 32063851
Serotonin 2C receptors (5-HTRs) are implicated in the pathomechanism and treatment of anxiety and depression. Recently, as a new biomarker of depression, alterations in the gamma power of the electroencephalogram...
5.
Bogathy E, Kostyalik D, Petschner P, Vas S, Bagdy G
Pharmacology
. 2019 Jan;
103(3-4):151-158.
PMID: 30673678
The endocannabinoid and serotonin (5-HT) systems have key roles in the regulation of several physiological functions such as motor activity and food intake but also in the development of psychiatric...
6.
Papp N, Vas S, Bogathy E, Katai Z, Kostyalik D, Bagdy G
Eur J Pharm Sci
. 2018 Jun;
121:347-355.
PMID: 29908300
Brain oscillations in the gamma frequency band of the electroencephalogram (EEG) have been implicated in several sensory and cognitive processes, and have also been associated with numerous neuropsychiatric disorders, including...
7.
Kostyalik D, Vas S, Katai Z, Kitka T, Gyertyan I, Bagdy G, et al.
BMC Neurosci
. 2014 Nov;
15:120.
PMID: 25406958
Background: Shortened rapid eye movement (REM) sleep latency and increased REM sleep amount are presumed biological markers of depression. These sleep alterations are also observable in several animal models of...
8.
Bergman P, Adori C, Vas S, Kai-Larsen Y, Sarkanen T, Cederlund A, et al.
Proc Natl Acad Sci U S A
. 2014 Aug;
111(35):E3735-44.
PMID: 25136085
Narcolepsy is a chronic sleep disorder, likely with an autoimmune component. During 2009 and 2010, a link between A(H1N1)pdm09 Pandemrix vaccination and onset of narcolepsy was suggested in Scandinavia. In...
9.
Kostyalik D, Katai Z, Vas S, Pap D, Petschner P, Molnar E, et al.
Exp Brain Res
. 2014 Jan;
232(3):935-46.
PMID: 24395141
Several multi-target drugs used in treating psychiatric disorders, such as antidepressants (e.g. agomelatine, trazodone, nefazodone, amitriptyline, mirtazapine, mianserin, fluoxetine) or most atypical antipsychotics, have 5-hydroxytryptamine 2C (5-HT2C) receptor-blocking property. Adaptive...
10.
Katai Z, Adori C, Kitka T, Vas S, Kalmar L, Kostyalik D, et al.
Psychopharmacology (Berl)
. 2013 Mar;
228(3):439-49.
PMID: 23515582
Rationale: Selective rapid eye movement sleep (REMS) deprivation using the platform-on-water ("flower pot") method causes sleep rebound with increased REMS, decreased REMS latency, and activation of the melanin-concentrating hormone (MCH)...